Search filters

List of works by Dominik Strzelecki

"Leaky Gut" as a Keystone of the Connection between Depression and Obstructive Sleep Apnea Syndrome? A Rationale and Study Design

scientific article published on 6 February 2022

A 10-week memantine treatment in bipolar depression: a case report. Focus on depressive symptomatology, cognitive parameters and quality of life

scientific article published on 16 December 2013

A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state

scientific article published on 16 February 2019

A history of obstetric complications is associated with the risk of progression from an at risk mental state to psychosis

scientific article published on 5 November 2017

Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex

scientific article

Analysis of vitamin D status in major depression

scientific article

Attention abnormalities in patients with chronic hepatitis C after pegylated interferon alpha and ribavirin treatment

scientific article published in September 2008

Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients--a preliminary 10-week open-label study

scientific article published in July 2013

BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

scientific article published on 20 May 2016

Can microbiology affect psychiatry? A link between gut microbiota and psychiatric disorders

scientific article published on 29 December 2018

Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR Spect

scientific article

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia

scientific article published on 15 April 2016

Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?

scientific article published on May 1, 2010

Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis

scientific article published on 17 October 2016

Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients

scientific article published in June 2008

Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?

scientific article published on 29 August 2019

Evaluation of white matter structure changes, as assessed in tractography, and cognitive dysfunctions in patients with early onset schizophrenia and their first-degree relatives

scientific article published on 29 August 2017

Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study

scientific article

Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture.

scientific article published on 19 August 2015

Impact of lithium alone or in combination with haloperidol on selected oxidative stress parameters in human plasma in vitro

scientific article published on 01 January 2016

In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present

scientific article published on 08 August 2018

Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder

scientific article

Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder.

scientific article published on 24 April 2015

MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).

scientific article published on 09 July 2016

No changes of cardiometabolic and body composition parameters after 6-month add-on treatment with sarcosine in patients with schizophrenia.

scientific article

Obstructive Sleep Apnea as an Acceleration Trigger of Cellular Senescence Processes through Telomere Shortening

scientific article published on 21 November 2021

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis

scientific article published on 05 March 2019

Olfactory identification in patients with schizophrenia - the influence of β-endorphin and calcitonin gene-related peptide concentrations.

scientific article published on 29 December 2016

Pegylated interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients.

scientific article published on 2 October 2008

Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up

scientific article published on 06 September 2020

Refeeding syndrome as treatment complication of anorexia nervosa

scientific article published on 30 October 2019

Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)

scientific article published on 10 August 2018

Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

scientific article published on 7 February 2018

Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double-blind randomized controlled PULSAR study)

scientific article published on 27 November 2020

Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state

scientific article published on 11 March 2019

Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia

scientific article

Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.

scientific article published on 22 August 2015

The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia

scientific article published on 31 December 2019

The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status - A case control study

scientific article published on 22 July 2020

Two grams of sarcosine in schizophrenia - is it too much? A potential role of glutamate-serotonin interaction.

scientific article published on 4 February 2014

[Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study]

scientific article published on 01 November 2011

[Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy].

scientific article published in November 2008

Paulina is supported by:

About Paulina

Help